Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: ICB
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, APOPTOSE, NEOPLASIAS MAMÁRIAS, CICLO CELULAR, ENDOCITOSE, NANOPARTÍCULAS, TRANSDUÇÃO DE SINAL CELULAR, MICROTÚBULOS, CÉLULAS CULTIVADAS DE TUMOR
ABNT
SALATA, Giovanna Cassone et al. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways. European Journal of Pharmaceutics and Biopharmaceutics, v. 215, p. 9 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2025.114837. Acesso em: 24 dez. 2025.APA
Salata, G. C., Malagó, I. D., Melo, G. B. de, Machado Neto, J. A., & Lopes, L. B. (2025). Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways. European Journal of Pharmaceutics and Biopharmaceutics, 215, 9 . doi:10.1016/j.ejpb.2025.114837NLM
Salata GC, Malagó ID, Melo GB de, Machado Neto JA, Lopes LB. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2025 ; 215 9 .[citado 2025 dez. 24 ] Available from: https://doi.org/10.1016/j.ejpb.2025.114837Vancouver
Salata GC, Malagó ID, Melo GB de, Machado Neto JA, Lopes LB. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2025 ; 215 9 .[citado 2025 dez. 24 ] Available from: https://doi.org/10.1016/j.ejpb.2025.114837
